Rapidai Announces $75 Million Growth Investment Led By Vista Credit Partners
07/27/23, 11:04 AM
Location
menlo parkMoney raised
$75 million
Industry
health care
manufacturing
Investors
Erin Erban, Vista Equity Partners, Vista Credit Partners
RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced $75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data and technology markets. The funding aims to drive platform innovation to support more disease states and go-to-market functions to accelerate growth in new regions and product verticals.
Company Info
Location
menlo park, california, united states
Additional Info
RapidAI and Rapid are registered trademarks of iSchemaView, Inc. RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes. Based on intelligence gained from over 10 million scans in more than 2,000 hospitals in over 100 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI — where AI meets patient care.